T-Liven PR®
GMP-ready human platelet lysate for closed-system bioprocessing
- GMP-ready: Manufactured under a certified ISO 9001:2015 Quality Management System, T-Liven PR meets the standards for clinical applications.
- Validated pathogen-reduction technology using E-Beam irradiation.
- Released against a validated T cell growth promotion assay.
- Available in bag format.
- Large donor pool lot sizes.
- Manufactured from outdated FDA/AABB approved apheresis platelet units.
- FDA Master File, Japan PMDA Certificate of Suitability.
- Used for manufacturing in US, EU, and other clinical trials globally.
- Typically used at concentrations ranging from 2% to 10%.
- Used in 2D and 3D expansion systems.
- Pathogen reduction applied per EU Pharmacopoeia.
- T-Cell growth verified: Released against a validated T-cell growth promotion assay, ensuring optimal performance for immune cell expansion.
- Pathogen-reduced: Utilizing validated E-Beam irradiation technology, this product offers added safety and reduced risk.
- Closed system compatible: Available in a convenient bag format, T-Liven PR can be seamlessly integrated into closed system bioprocessing workflows.
- Optimal cell quality: Promotes improved in vitro and in vivo T-cell performance, including enhanced proliferation, prolonged persistence, and superior anti-tumor response.
- Improved phenotype: Consistently produces cells with improved naïve and central memory phenotype compared to expansion in FBS or AB Serum.
- Reduced variability: A biodefined composition contributes to lower lot-to-lot variability compared to other options like FBS or AB Serum.
- Flexible usage: Can be used as a culture supplement to replace FBS or AB Serum and supports a wide range of cell types beyond T-cells, including MSCs, NK cells, and endothelial cells. Maintains a fully closed system during storage and shipping.
- Improves traceability and chain-of-identity.
Please download T-Liven PR resources here:
Frequently asked questions
T-Liven PR is verified to support T cell growth. Each lot is released using a T cell growth verification assay. It’s packed in bags for compatibility in common manufacturing systems. Like nLiven PR, T-Liven PR has undergone the additional step of pathogen-reduction.
Ex vivo expansion of cells such as MSCs, ASCs, T cells, etc. Please connect with us to learn which BioLife Solutions hPL is right for your application.
Yes. We are ISO9001:2015 certified.